Loading
Get National Cancer Institute Clinical Data Reporting Form - Lung 2008-2025
How it works
-
Open form follow the instructions
-
Easily sign the form with your finger
-
Send filled & signed form or save
Related links form
The targeted therapy Osimertinib (Tagrisso) was approved by the FDA in 2021 to be given after surgery—that is, as adjuvant therapy—to people with early-stage NSCLC that has certain mutations in the EGFR gene.
Industry-leading security and compliance
US Legal Forms protects your data by complying with industry-specific security standards.
-
In businnes since 199725+ years providing professional legal documents.
-
Accredited businessGuarantees that a business meets BBB accreditation standards in the US and Canada.
-
Secured by BraintreeValidated Level 1 PCI DSS compliant payment gateway that accepts most major credit and debit card brands from across the globe.